Divalproex Sodium | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Divalproex Sodium
USP

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

Contact Supplier

Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

xyz-pharma-m-2025-01-06

Contact Supplier

Divalproex Sodium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 36 USDMF, 10 CEP/COS, 3 JDMF, 8 EU WC, 9 KDMF, 15 NDC API, 36 Listed Suppliers, $ API Reference Price

69 API Suppliers
36 USDMF
10 CEP/COS
3 JDMF
8 EU WC
9 KDMF
15 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

266 FDF Dossiers, 109 FDA Orange Book, 57 Europe, 17 Canada, 30 Australia, 17 South Africa, 36 Listed Dossiers

266 FDF Dossiers
109 FDA Orange Book
57 Europe
17 Canada
30 Australia
17 South Africa
36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 125MG VALPROIC ACID, TABLET, DELAYED RELEASE;ORAL - EQ 250MG VALPROIC ACID, TABLET, DELAYED RELEASE;ORAL - EQ 500MG VALPROIC ACID, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 125MG VALPROIC ACID, TABLET, EXTENDED RELEASE;ORAL - EQ 250MG VALPROIC ACID, TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID

CAPSULE;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SYRUP;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 125MG VALPROIC ACID
TABLET, DELAYED RELEASE;ORAL - EQ 250MG VALPROIC ACID
TABLET, DELAYED RELEASE;ORAL - EQ 500MG VALPROIC ACID
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 125MG VALPROIC ACID
TABLET, EXTENDED RELEASE;ORAL - EQ 250MG VALPROIC ACID
TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID

RELATED EXCIPIENT COMPANIES

12 Evonik, 3 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 14 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 11 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 38 BASF, 2 Clariant, 18 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 16 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 34 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

108 Fillers, Diluents & Binders, 89 Coating Systems & Additives, 52 Direct Compression, 52 Controlled & Modified Release, 43 Disintegrants & Superdisintegrants, 42 Solubilizers, 42 Thickeners and Stabilizers, 37 Taste Masking, 35 Granulation, 32 Film Formers & Plasticizers, 26 Topical, 23 Parenteral, 23 Lubricants & Glidants, 21 Co-Processed Excipients, 18 Chewable & Orodispersible Aids, 11 Emulsifying Agents, 10 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

108 Fillers, Diluents & Binders
89 Coating Systems & Additives
52 Direct Compression
52 Controlled & Modified Release
43 Disintegrants & Superdisintegrants
42 Solubilizers
42 Thickeners and Stabilizers
37 Taste Masking
35 Granulation
32 Film Formers & Plasticizers
26 Topical
23 Parenteral
23 Lubricants & Glidants
21 Co-Processed Excipients
18 Chewable & Orodispersible Aids
11 Emulsifying Agents
10 Rheology Modifiers
10 API Stability Enhancers
9 Empty Capsules
6 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 61 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
61 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 91 Finished Drug Prices, 5 Annual Reports

6 US Medicaid Prescriptions
91 Finished Drug Prices
5 Annual Reports

MARKET PLACE

25 APIs, 16 FDF Dossiers

25 APIs
16 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 5 Others

2 EDQM
3 USP
5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 38 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11224201

02 11708707

03 11708729

filter Description Reset all filters

3 All

01 1Divalproex Sodium (200 mg)

02 1Valproic Acid (500 mg)

03 1Valproic Acid Related Compound A (0.25 mL) (diallyl acetic acid)

filter CAS Number Reset all filters

3 All

01 176584-70-8

02 199-66-1

03 199-67-2

Product Main Page

01

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Valproic Acid Related Compound A (0.25 mL) (d...

CAS Number : 99-67-2

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1708729

Current Lot : H0I276

Previous Lot : G0C398 (31-JAN-2012)

NDC Code :

Product Web Link

Digital Content

02

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Valproic Acid (500 mg)

CAS Number : 99-66-1

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1708707

Current Lot : R051T0

Previous Lot : M0G249 (30-APR-2018)

NDC Code :

Product Web Link

Digital Content

03

USP

PharmaVenue

Not Confirmed

USP

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Divalproex Sodium (200 mg)

CAS Number : 76584-70-8

Quantity Per Vial :

Price ($) : 230

Catalog Number : 1224201

Current Lot : R01500

Previous Lot : F0G392 (31-AUG-2016)

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?